[Commentary to the article: Kahn SE, Haffner SM, Heise MA, et al. ADOPT Study Group. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006; 355: 2427-43]. [electronic resource]
- Kardiologia polska Feb 2007
- 214-6; discussion 216-7 p. digital